Cubist Systematic Strategies, LLC Spectrum Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $5,235 - $8,508	16,362 New	16,362 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $12,840 - $25,680	18,343 New	18,343 $14,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $41,267 - $104,151	-65,504 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $83,190 - $158,519	65,504 New	65,504 $83,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $237,658 - $422,258	-110,539 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $290,670 - $447,572	100,578 Added 1009.72%	110,539 $415,000
Q1 2021 May 17, 2021	SELL	$2.9 - $4.09 $69,979 - $98,695	-24,131 Reduced 70.78%	9,961 $32,000
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $15,804 - $24,034	4,676 Added 15.9%	34,092 $116,000
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $34,071 - $55,835	11,395 Added 63.23%	29,416 $120,000
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $173 - $277	82 Added 0.46%	18,021 $61,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $49,986 - $94,236	-27,315 Reduced 60.36%	17,939 $42,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $49,276 - $145,717	14,079 Added 45.16%	45,254 $165,000
Q3 2019 Nov 14, 2019	SELL	$7.03 - $9.7 $457,083 - $630,684	-65,019 Reduced 67.59%	31,175 $259,000
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $21,991 - $33,644	-2,988 Reduced 3.01%	96,194 $828,000
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $138,660 - $180,808	15,271 Added 18.2%	99,182 $1.06 Million
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $532,133 - $1.41 Million	83,276 Added 13114.33%	83,911 $734,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $10,490 - $15,760	635 New	635 $11,000
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $522,764 - $749,544	-32,490 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $434,066 - $673,517	32,490	32,490 $616,000

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account